Answers are grounded in this paper and cite their sources.
To evaluate whether MRI-derived functional and morphologic biomarkers are associated with clinical severity and prognosis in chronic liver disease (CLD). In this retrospective single-center study, 165 adults with chronic liver disease (CLD) who underwent gadoxetic acid-enhanced MRI were included. Functional Liver Imaging Score (FLIS) was assessed on 20-min hepatobiliary-phase images, and Liver Surface Nodularity (LSN) was measured on contrast-enhanced axial T1-weighted images using semi-automated software. Spearman correlation analysis was performed for associations with Model for End-Stage Liver Disease 3.0 (MELD 3.0), and Albumin-Bilirubin score (ALBI). Time-to-event analyses for liver transplantation or death within 4 years were performed using Kaplan–Meier analysis and Cox proportional hazards models. Receiver operating characteristic (ROC) analysis was used to evaluate the performance of FLIS for predicting 1-year transplant-free survival (TFS). FLIS showed moderate inverse correlations with MELD 3.0 (ρ = − 0.532, p < 0.001) and ALBI score (ρ = − 0.541, p < 0.001). LSN showed weak positive correlations with MELD 3.0 (ρ = 0.154, p = 0.049) and ALBI score (ρ = 0.184, p = 0.018). In univariable Cox analysis, older age, lower FLIS, higher MELD 3.0, higher ALBI score, and LSN cutoff ≥ 3 were associated with a higher risk of liver transplantation/death. In multivariable analysis, age (hazard ratio (HR), 1.05; p < 0.001), MELD 3.0 (HR, 1.08; p = 0.003) and FLIS group (0–3 vs 4–6 points; HR, 2.39; p = 0.007) remained independently associated with liver transplantation or death. For 1-year TFS, FLIS with an optimal cutoff of ≤ 3 yielded an area under the curve (AUC) of 0.71 (95% confidence interval (CI), 0.61–0.82). Our findings suggest that MRI-derived functional and morphologic biomarkers, particularly FLIS, may provide noninvasive imaging markers of disease severity and prognosis in patients with CLD. Prospective studies with long-term clinical outcomes are needed to define their role in risk stratification and transplant decision-making.
No takes yet. Share an insight, caveat, or question.
Taktak et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: